Author Archives: John E. Fitzgibbon Jr.

This week’s trip through the IPO Valley takes a different route. The calendar lists four deals – one “blank check” and three technology companies. That’s right – three are technology IPOs. Over the last couple of years, the energy and the health-care sectors have led the parade, but this week returns to yesteryear. Technology is […]

This week’s IPO calendar looks much like last week’s. That one was mostly wing flapping and no flying. Nevertheless, it produced nine deals. This week, the world is looking at three offerings. One issue is already traded on the Euronext Brussels, the other is out of China, and the remaining one comes from the U.S. […]

Anytime a weekly IPO calendar is set to raise over $1 billion, it should draw interest. This week is shaping up that way, but investors’ feedback is not all that exciting. Their conclusion: Expect some wing flapping, but no flying from this group of six deals. That’s what happened last week. To recap: For the […]

The IPO calendar kicks off the merry month of May with six offerings. Two are from the energy sector, while three are from the biotech sector and one is a real estate investment trust (REIT). They are expected to raise over $1.7 billion, but more on this in a minute. Over the years, May’s IPO […]

As the IPO calendar gears up for its final April run, seven initial public offerings are set for the last week of the month. Some services, though, see eight IPOs, but there is a reason for the difference. The reason is Verona Pharma plc. The IPO’s proposed symbol is “VRNA” and the deal is to […]